Sumary of UK set to offer under-30s non-AstraZeneca jab:
- The UK should give an alternative to Oxford/AstraZeneca COVID-19 vaccine to under 30s where possible due to a “vanishingly”.
- Safety concerns have prompted more than a dozen countries in recent weeks to suspend use of the vaccine, which has been given to tens of millions of people across Europe, after reports linking it to a brain blood clotting disorder in a few dozen recipients..
- Wei Shen Lim, chair of the the UK Joint Committee on Vaccination and Immunisation (JCVI), said that based on the available data and evidence, the committee has advised that it was preferable for adults aged under 30 with no underlying conditions to be offered an alternative to the AstraZeneca vaccine where available..
- He said that for younger people, where the risks of hospitalisation were much lower, the risk/benefit calculation of the Oxford/AstraZeneca shot meant others vaccines were preferable..
- He said people should continue to have a second dose of the AstraZeneca shot if they had received a first dose..
- AAP It came after the UK MHRA medicine regulator identified a possible side-effect from the COVID-19 vaccine developed by Oxford University and AstraZeneca involving rare brain blood clotting..
- Chief executive June Raine said that the benefits of the shot outweighed the risks for the vast majority, echoing an update from the Europe Union medicine regulator also made on Wednesday..
- The EU and UK medicine regulators have been investigating small numbers of reports of a brain blood clots, know as cerebral venous sinus thrombosis (CVST), that have occurred in combination with unusually low blood platelet levels after people have been given the shot…